Espansione Group’s eye light_V2 02
June 3, 2024

Espansione Group’s eye-light® Expands Its Horizons: New CE (MDR) Mark for Corneal and Retinal Care

Espansione Group (Zona Artigianale Funo BO, Italy), a leader in medtech innovation in ophthalmology, announced today a major milestone for…

latest posts
The Blind Spot in APAC’s Vision Health
April 23, 2025

Roche Survey Highlights Asia Pacific’s Silent Struggle with Eye Care

[TFG] Advancing Eye Care Series Carolyn Majcher
April 1, 2025

Advancing Eye Care Series: Exploring Dry AMD and GA with Dr. Carolyn Majcher

MicroMovements, Mega Impact The Secret to Boosting Visual Acuity thumbnail
February 14, 2025

Micro-Movements, Mega Impact: The Secret to Boosting Visual Acuity

ThThumbnail article _ 1200x675_Age and Gender Influence the Risk of Side Effects in Gene Therapy
February 12, 2025

Age and Gender Influence the Risk of Side Effects in Gene Therapy

Blinding Disease Weight Loss Drug Link EMA Announces Start of Semaglutide Investigation
January 22, 2025

Blinding Disease-Weight Loss Drug Link: EMA Announces Start of Semaglutide Investigation

Ophthalmology hands forming an eye (1)
October 29, 2024

Seeing Beyond the Horizon: How Research Collaborations are Advancing Eye Care in Asia-Pacific

Untitled 1
August 20, 2024

Atsena Therapeutics Receives FDA RPD Designation for X-Linked Retinoschisis Gene Therapy Candidate

Espansione Group’s eye light_V2 02
June 3, 2024

Espansione Group’s eye-light® Expands Its Horizons: New CE (MDR) Mark for Corneal and Retinal Care

Discover our fascinating content at issuu

explore